Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Balluff releases BMP magnetic position sensors April 29, 2019 Bank employee unions threaten strike on August 22 over mergers, NPAs June 30, 2017 Bill’s Top 10 Automation & Control Trends for 2019 – Accelerating Change & Reaching the Tipping Point January 29, 2019
Bill’s Top 10 Automation & Control Trends for 2019 – Accelerating Change & Reaching the Tipping Point January 29, 2019